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ABSTRACT
The highly conserved Tof1/Timeless proteins min-
imise replication stress and promote normal DNA
replication. They are required to mediate the DNA
replication checkpoint (DRC), the stable pausing of
forks at protein fork blocks, the coupling of DNA he-
licase and polymerase functions during replication
stress (RS) and the preferential resolution of DNA
topological stress ahead of the fork. Here we demon-
strate that the roles of the Saccharomyces cerevisiae
Timeless protein Tof1 in DRC signalling and resolu-
tion of DNA topological stress require distinct N and
C terminal regions of the protein, whereas the other
functions of Tof1 are closely linked to the stable in-
teraction between Tof1 and its constitutive binding
partner Csm3/Tipin. By separating the role of Tof1 in
DRC from fork stabilisation and coupling, we show
that Tof1 has distinct activities in checkpoint acti-
vation and replisome stability to ensure the viable
completion of DNA replication following replication
stress.
INTRODUCTION
The faithful replication of the genome by the DNA repli-
cation machinery is hindered by a range of exogenous and
endogenous factors that are capable of disrupting replica-
tion forks. Such cellular events are a prominent feature of
the early stages of cancer and have been collectively referred
to as replication stress (RS) (1). RS occurs when either
the helicase or polymerase activities of the replisome are
impeded. Potential impediments include chemical changes
to the DNA, stable DNA-binding protein complexes, nu-
cleotide deficiency and DNA topological stress (2,3).
On encountering RS, the replisome is thought to be sta-
bilised at the replication fork until the impeding context is
removed or bypassed and replication restarted (4). A failure
to stabilise the replisome is associated with erroneous pro-
cessing of the replication fork, leading to either toxic recom-
bination intermediates or disruption of replication restart.
The activation of checkpoint pathways is essential for
replication fork stabilisation and restart (5). Following RS,
ATR type kinases (Mec1 in Saccharomyces cerevisiae) are
activated by the accumulation of excessive RPA-coated sin-
gle stranded DNA (6,7). ATR/Mec1 then acts with media-
tor proteins to activate effector kinases which promote fork
stability, regulate nucleotide metabolism, and inhibit the fir-
ing of further replication origins (8). The mediator proteins
required for effector kinase activation can act either at the
replication fork, commonly referred to as the DNA repli-
cation checkpoint (DRC), or independently of the fork, re-
ferred to as the DNA damage checkpoint (DDC). Medi-
ator proteins in the DRC include the replisome proteins
Mrc1/Claspin (Sc Mrc1) (9) and Tof1/Swi1/Timeless (Sc
Tof1) (10).
Tof1 appears to act as a nexus for various processes re-
lating to both stabilising the replication fork during RS and
ensuring faithful chromosome inheritance. In addition to
its role in activating effector kinases, Tof1, Mrc1 and the
Tof1 interacting protein Csm3/Swi3/Tipin (Sc Csm3) are
required to stimulate DNA replication in vivo and in vitro
(11–14), and to couple helicase and polymerase activities
(15–19). Independently of Mrc1, the Tof1-Csm3 complex
is also required for pausing of replication forks at stable
protein-DNA barriers (11,20,21) and to focus the action of
topoisomerases ahead of the fork to prevent excessive fork
rotation during DNA replication (22). This latter activity
has been linked to the observation that the C terminus of
Tof1 and the type IB topoisomerase Top1 interact (23), po-
tentially ensuring a relative enrichment of Top1 at the repli-
cation fork (3,22). Consistent with this model, Tof1 is re-
quired to recruit Top1 to replicating regions in vivo (24).
In addition, both tof1Δ and csm3Δ (but not mrc1Δ) cells
are acutely sensitive to the chemotherapeutic drug camp-
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tothecin (CPT), which stabilises the covalently DNA-bound
intermediate of Top1 (25–27). The potential linkage be-
tween the Tof1-Csm3-dependent activities of fork pausing,
resolving DNA topological stress and resistance to CPT
treatment is unclear.
To attempt to define the molecular relationships between
the processes that involve Tof1, we have generated a series
of truncations across the C terminus of Tof1 and assessed
whether the truncated proteins are capable of maintaining
the functions of Tof1 in activating the DRC, replication fork
pausing, helicase-polymerase coupling and preventing ex-
cessive fork rotation in response to DNA topological stress.
We find that the far C terminus is required to resolve DNA
topological stress but not for fork pausing, replisome cou-
pling, CPT resistance or DRC activation signalling. The
near C terminus is required for fork pausing, fork coupling
and CPT resistance but not DRC signalling. This region is
also required for the interaction between Tof1 and Csm3.
We also find that the N terminal half of Tof1 alone is suffi-
cient for DRC signalling. Our data indicate a modular func-
tionality for Tof1 with the N terminal half supporting the
DRC, the far C terminus recruiting Top1 to the fork, and the
interaction between Tof1 and Csm3 closely linked to fork
pausing, replisome coupling and CPT resistance.
MATERIALS AND METHODS
Yeast strains, plasmids and primers
All yeast strains in this study were generated in the W303
background (ade2–1 ura3–1 his3–11, trp1–1 leu2–3, can1–
100) and are listed in Table 1.
See Table 2 for all plasmids used in this study.
Generation of yeast strains expressing truncated forms of
Tof1 was carried out in two steps. First, codon optimised
TOF1 gene was cut out from a pRS306/Tof1-Gal-CBP-
Csm3 plasmid (gift from Diffley lab) (12) by NotI diges-
tion and cloned into pFA6-natNT2. The codon optimised
TOF1 was then mutagenised using QuikChange Lightning
Site Directed Mutagenesis kits (Agilent, 210518) according
to manufacturer’s instructions, with primer sets designed
to incorporate premature stop codons into the TOF1 open
reading frame. Mutagenesis was confirmed by sequencing
before PCR amplification and insertion of the mutagenised
sequence and Nourseothricin resistance gene into the en-
dogenous TOF1 locus of yeast cells using lithium acetate
transformation.
Plasmid pRS426-RFB was generated by a two-fragment
Gibson assembly. Specifically, a single RFB site was PCR-
amplified from plasmid 4xRFB (gift from Luis Aragon) cor-
responding to the sequence from Saccharomyces cerevisiae
S288C Chromosome XII: 459799–460920. This was assem-
bled with PfoI-linearized pRS426 using the NEBuilder®
HiFi DNA Assembly Cloning Kit (New England Biolabs,
E5520S).
Media and cell-cycle synchronisation
For plasmid catenation experiments in top2–4 pRS316-
containing strains, cells were grown to mid-log phase in syn-
thetic complete media without uracil +2% glucose, before
being re-suspended in YP 2% Glucose (YPD). Cells were
arrested in G1 by addition of 10 g/ml alpha factor pep-
tide (Genscript) for 1.5 h, after which a second dose of alpha
factor (5 g/ml) was added. When >90% of cells were un-
budded, cultures were shifted to the restrictive temperature
for top2–4 (37◦C) 1 h before release into S-phase achieved
by washing three times with YPD at 37◦C. Time 0 indicates
the time from addition of the first wash. 50 g/ml noco-
dazole was added to cultures at 45 min to prevent mitotic
entry, and at 80 min from release 10 ml samples for 2D gel
and Southern blotting analysis were collected by centrifu-
gation and snap-freezing the pellets in liquid nitrogen.
For fork pausing experiments cells containing pRS426-
RFB were grown to mid-log phase in synthetic complete
media without uracil +2% glucose. 10 ml cultures were col-
lected by centrifugation and snap-freezing the pellets in liq-
uid nitrogen.
For experiments involving treatment with HU, cells were
grown in YPD to mid-log phase before either HU being
added to 200 mM for 2 h (for Rad53 activation experiments
in Figure 5A) or for experiments started with a G1 arrest,
mid-log cells were treated with 10 g/ml alpha factor pep-
tide. To release cultures into the cell cycle, when cells were
>90% unbudded, cultures were washed 3 times in YPD and
re-suspended after the third wash in YPD containing 200
mM HU. Time 0 was designated as the time from the first
wash. Time points were taken as indicated. For release from
HU experiments, HU-containing media was washed off of
cells by washing three times with YPD before re-suspending
in YPD. Time 0 is taken as the time from the first YPD
wash.
For RPA ChIP experiments cells were grown in YP +2%
raffinose to mid-log phase at 25◦C, before being arrested
with 10 g/ml alpha factor peptide. After 1 h 45 min
2% galactose and an additional 5 g/ml alpha factor was
added. After 2 h, when cells were >90% unbudded, 25
g/ml doxycycline was added. Fifteen minutes after doxy-
cycline addition the temperature was switched to 37◦C and
incubated for 1 h. Cells were then released by washing 3
times with pre-heated YP 2% raffinose 2% galactose with
25 g/ml doxycycline and resuspended in the same media
supplemented with 200 mM HU. Time 0 was taken as the
time from the first wash. Samples were then incubated for
1 h at 37◦C before being fixed by resuspending in YP + 1%
formaldehyde (Sigma) for 45 min at 25◦C. 125 mM glycine
was then added followed by a 5 min incubation at 25◦C.
Cells were washed with PBS before being pelleted and snap-
frozen in liquid nitrogen.
TCA extraction
10 ml of mid-log yeast cultures were centrifuged at 3500 rpm
for 5 min and the resulting cell pellets were snap-frozen in
liquid nitrogen before storing at −80◦C. All further steps
were carried out on ice, and centrifugation and homogeni-
sation steps at 4◦C. 200 l of 20% TCA was added to
thawed cell pellets and the cell suspension was transferred to
screw-cap tubes containing 500 l of 0.5 mm zirconia/silica
beads (BioSpec Products). Cells were homogenised using a
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Table 1. Yeast strains used in this study
No. Name Genotype Source
1991 wt MATa, ade2–1 his3–11 leu2–3 trp1–1 ura3–1 can1–100,
UBR1::GAL1–10-Ubiquitin-M-LacI fragment-Myc-UBR1 (HIS3),
leu2–3::pCM244 (CMVp-tetR’-SSN6, LEU2) x3
S. Tanaka, J. F. Diffley,
Nature Cell Biology. 4,
198–207 (2002).
1993 tof1Δ 1991 + TOF1::hphMX This study
1528 TOF1 1991 +TOF1::TOF1-codon-optimised-wildtype (NATNT2) This study
1549 tof1 627 1991 + TOF1::tof1-codon-optimised-627–1238Δ (NATNT2) This study
1596 tof1 762 1991 + TOF1::tof1-codon-optimised-762–1238Δ (NATNT2) This study
1589 tof1 830 1991 + TOF1::tof1-codon-optimised-830–1238Δ (NATNT2) This study
1546 tof1 997 1991 + TOF1::tof1-codon-optimised-997–1238Δ (NATNT2) This study
1537 tof1 1182 1991 + TOF1::tof1-codon-optimised-1182–1238Δ (NATNT2) This study
2188 TOF1 wt TAP 1991 + endogenous TOF1 tagged with TAP (KanMX) This study
2182 TOF1TAP 1991 + TOF1::tof1-codon-optimised-wildtype-TAP (KanMX) This study
2183 tof1 627 TAP 1991 + TOF1::tof1-codon-optimised-627–1238Δ-TAP (KanMX) This study
2184 tof1 762 TAP 1991 + TOF1::tof1-codon-optimised-762–1238Δ-TAP (KanMX) This study
2185 tof1 830 TAP 1991 + TOF1::tof1-codon-optimised-830–1238Δ-TAP (KanMX) This study
2186 tof1 997 TAP 1991 + TOF1::tof1-codon-optimised-997–1238Δ-TAP (KanMX) This study
2187 tof1 1182 TAP 1991 + TOF1::tof1-codon-optimised-1182–1238Δ-TAP (KanMX) This study
2288 TOF1 wt
mrc1–3FLAG
1528 + Mrc1–3FLAG (NATNT2) This study
2191 TOF1 wt-TAP
mrc1–3FLAG
2182 + Mrc1–3FLAG (NATNT2) This study
2192 tof1 627-TAP
mrc1–3FLAG
2183 + Mrc1–3FLAG (NATNT2) This study
2194 tof1 762-TAP
mrc1–3FLAG
2184 + Mrc1–3FLAG (NATNT2) This study
2195 tof1 830-TAP
mrc1–3FLAG
2185 + Mrc1–3FLAG (NATNT2) This study
2196 tof1 997-TAP
mrc1–3FLAG
2186 + Mrc1–3FLAG (NATNT2) This study
2197 tof1 1182-TAP
mrc1–3FLAG
2187 + Mrc1–3FLAG (NATNT2) This study
2465 GAL-HA-TOF1 wt 1991 + TOF1:: GAL-S-HA-TOF1-codon-optimised-wt (TRP) This study
2466 GAL-HA-tof1 627 1991 + TOF1:: GAL-S-HA-TOF1-codon-optimised-627–1238Δ (TRP) This study
2467 GAL-HA-tof1 997 1991 + TOF1:: GAL-S-HA-TOF1-codon-optimised-997–1238Δ (TRP) This study
2468 GAL-HA-tof1 1182 1991 + TOF1:: GAL-S-HA-TOF1-codon-optimised-1182–1238Δ (TRP) This study
2414 wt TOF1(diploid) MAT a/alpha (diploid)homozygous: ade2–1 his3–11 leu2–3 trp1–1
ura3–1 can1–100, UBR1::GAL1–10-Ubiquitin-M-LacI
fragment-Myc-UBR1 (HIS3), leu2–3::pCM244 (CMVp-tetR’-SSN6,
LEU2) x3, heterozygous TOF1::tof1-codon-optimised-wildtype
(NATNT2)
This study
2420 tof1 627 TAP
top1-MYC
(diploid)
MAT a/alpha (diploid) heterozygous: ade2–1 his3–11 leu2–3 trp1–1
ura3–1 can1–100, UBR1::GAL1–10-Ubiquitin-M-LacI
fragment-Myc-UBR1 (HIS3), leu2–3::pCM244 (CMVp-tetR’-SSN6,
LEU2) x3 TOF1::tof1-codon-optimised-627–1238Δ-TAP (KanMX)
Top1–9MYC(hphMX)
This study
2463 tof1 997 TAP
top1-myc (diploid)
MAT a/alpha (diploid)homozygous: ade2–1 his3–11 leu2–3 trp1–1
ura3–1 can1–100, UBR1::GAL1–10-Ubiquitin-M-LacI




2416 tof1 1182 TAP
top1-myc (diploid)
MAT a/alpha (diploid)homozygous: ade2–1 his3–11 leu2–3 trp1–1
ura3–1 can1–100, UBR1::GAL1–10-Ubiquitin-M-LacI




1988 csm3Δ 1991 + CSM3:: NATNT2 This study
684 tof1Δ rad9Δ 1993 + rad9::NATNT2 This study
2405 csm3Δ rad9Δ 1988 + rad9::KanMX This study
1718 TOF1 wt rad9Δ 1528 + rad9::KanMX This study
1719 tof1 627 rad9Δ 1549 + rad9::KanMX This study
1777 tof1 762 rad9Δ 1596 + rad9::KanMX This study
1767 tof1 830 rad9Δ 1589 + rad9::KanMX This study
1722 tof1 997 rad9Δ 1546 + rad9::KanMX This study
1769 tof1 1182 rad9Δ 1537 + rad9::KanMX This study
1762 TOF1 wt top2–4
pRS316
1528 + top2–4,pRS316 (URA) This study
1610 tof1 627 top2–4
pRS316
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Table 1. Continued
No. Name Genotype Source
2290 tof1 762 top2–4
pRS316
1596 + top2–4,pRS316 (URA) This study
1717 tof1 830 top2–4
pRS316
1589 + top2–4,pRS316 (URA) This study
1763 tof1 997 top2–4
pRS316
1546 + top2–4,pRS316 (URA) This study
1611 tof1 1182 top2–4
pRS316
1537 + top2–4,pRS316 (URA) This study
1731 wt pRS426-RFB 1991 + pRS426–1xRFB (URA) This study
1730 tof1Δ pRS426-RFB 1993 + pRS426–1xRFB (URA) This study
1732 TOF1 wt
pRS426-RFB
1528 + pRS426–1xRFB (URA) This study
1739 tof1 627
pRS426-RFB
1549 + pRS426–1xRFB (URA) This study
2333 tof1 762
pRS426-RFB
1596 + pRS426–1xRFB (URA) This study
1740 tof1 830
pRS426-RFB
1589 + pRS426–1xRFB (URA) This study
1733 tof1 997
pRS426-RFB
1546 + pRS426–1xRFB (URA) This study
1741 tof1 1182
pRS426-RFB
1537 + pRS426–1xRFB (URA) This study
Table 2. Plasmids used in this study
Plasmid name Source Used for
pRS306/Tof1-
Gal-CBP-Csm3
Yeeles et al., 2017 Generation of pBAK004 containing TOF1-codon optimised sequence
upstream of NATNT2 selection marker
PBAK004
(TOF1-NATNT2)
This study Used as template for site-directed mutagenesis of TOF1 codon-optimised
gene
tof1 627-NATNT2 This study Used as PCR template to generate fragment:
tof1-codon-optimised-627–1238-NATNT2 for yeast transformation into
endogenous TOF1 locus
tof1 762-NATNT2 This study Used as PCR template to generate fragment:
tof1-codon-optimised-762–1238-NATNT2 for yeast transformation into
endogenous TOF1 locus
tof1 830-NATNT2 This study Used as PCR template to generate fragment:
tof1-codon-optimised-830–1238-NATNT2 for yeast transformation into
endogenous TOF1 locus
tof1 997-NATNT2 This study Used as PCR template to generate fragment:
tof1-codon-optimised-997–1238-NATNT2 for yeast transformation into
endogenous TOF1 locus
tof1 1182-NATNT2 This study Used as PCR template to generate fragment:
tof1-codon-optimised-1182–1238-NATNT2 for yeast transformation into
endogenous TOF1 locus
pRS316 Sikorski, R. S. and
Hieter, P. (1989)
Transformed into tof1 top2–4 strains for fork rotation/catenation assay
4XRFB Luis Aragon Lab
(unpublished)
Used as PCR template to amplify 1xRFB sequence for cloning into pRS426
pRS426-RFB This study Transformed into tof1 top2–4 strains for fork pausing assay
4 × 1 min pulses, with 1 min on ice in between pulses. Beads
were separated from the lysate by piercing the tubes and cen-
trifugation of the mixtures into fresh tubes at 3000 rpm for
2 min. Beads were washed once with 600 l 5% TCA and
centrifuged again into tubes containing the cell lysate. Cell
extract/TCA mixtures were then centrifuged at 13 000 rpm
for 5 min before removing all TCA from the resulting pel-
lets. This step was repeated once to ensure complete removal
of all TCA. To the pellets 200 l of 1× sample buffer was
added before boiling samples for 5 min. Samples were spun
at 13 000 rpm for 5 min and the resulting supernatants were
collected and stored at −20◦C for SDS-PAGE and western
blotting analysis.
SDS-PAGE and western blotting
Protein extracts prepared by TCA extraction were run on
either 8%, 10% or 12% SDS-PAGE gels before being wet-
transferred to nitrocellulose membranes at 50V for 90 min,
4◦C. Proteins were visualised by staining in Ponceau for 30
seconds before membranes were blocked in 5% milk (Mar-
vel) PBS 0.2% Tween-20 (PBS-T). All primary antibodies
were diluted in 5% milk PBS-T and incubated overnight at
4◦C. In between primary and secondary antibody incuba-
tions membranes were washed 3 times with PBS-T for 15
min. Secondary antibodies were diluted in 5% milk PBS-T
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Proteins were detected using Western Lightning Plus-ECL
(Perkin-Elmer, NEL104001EA) and images were acquired
on an ImageQuant LAS4000 system (GE Healthcare). Den-
sitometry analysis was carried out using ImageQuant TL
software.
Primary antibodies used for immunoblotting in this
study: OctA-Probe Antibody 1:1000 (for detecting FLAG-
tagged proteins) (sc-166355), anti-Csm3 (28), anti-PAP
1:1000 (for detecting TAP-tagged proteins) (Sigma-Aldrich,
P1291), anti-Rad53 1:2000 (abcam ab104232), anti-HA
1:1000 (Roche 12CA5), anti-c-Myc 1:1000 (sc-9E10). Sec-
ondary antibodies used in this study: anti-mouse-HRP
1:1000 (Dako P0260), anti-rabbit-HRP 1:1000 (Dako
P0448) and anti-sheep-HRP 1:10 000 (Sigma-Aldrich
A3415).
TAP pulldowns
200 ml of mid-log yeast cultures were centrifuged for 5 min
at 3500 rpm and washed once in ice-cold PBS. The resulting
cell pellet was snap-frozen in liquid nitrogen and stored at
−80◦C before proceeding. Frozen pellets were re-suspended
in 0.5 ml of ice-cold lysis buffer (50 mM HEPES pH 7.5,
300 mM KCl, 5 mM EDTA, 10 mM MgOAc, 10% glycerol,
80 mM Beta-glycerophosphate, 0.01% Triton X-100, 1 pro-
tease inhibitor tablet (cOmplete™, EDTA-free Protease In-
hibitor Cocktail, Roche) and 1 phosphatase inhibitor tablet
(PhosSTOP™, Roche) per 50ml of lysis buffer) in screw-cap
tubes. 500 l of zirconia/silica beads (BioSpec Products)
were added and the cell suspensions were homogenised us-
ing the FastPrep-24 (MP Biomedicals) on max speed (6.5
m/s) for 4 pulses of 1 min each, with 3 min on ice in between
each pulse. Beads were separated from the lysate by piercing
the tubes and centrifugation into fresh tubes at 3000 rpm for
2 min. For Csm3 pulldowns in Figure 7 the supernatants
were immediately cleared by centrifugation at 13 000 rpm
for 30 min at 4◦C before addition of beads. For Top1 pull-
downs in Supplementary Figure S2 the lysate was first
treated with 100 U benzonase (Merck) for 40 min at 4◦C be-
fore being cleared by centrifugation at 13 000 rpm for 30 min
at 4◦C. Cleared supernatants were transferred to fresh tubes
before starting the pulldown. 20 l of IgG Sepharose 6 Fast
Flow affinity resin (GE-Healthcare, #17096901) for each
pulldown were pre-washed 3 times in cold lysis buffer be-
fore being added to the cleared cell lysates. The lysate/bead
mixtures were incubated at 4◦C on a rotating platform for
2 h and subsequently washed 4 times with 1 ml ice cold
lysis buffer. For Csm3 pulldowns in Figure 7 beads were
washed in Poly-Prep® Chromatography Columns (Bio-
Rad #7311550) and the bound fraction was eluted in 0.5 ml
of 0.2 M glycine pH 3.0. For Top1 pulldowns in Supplemen-
tary Figure S2 the beads were washed in microcentrifuge
tubes 4 times for 5 min on a rotating platform at 4◦C, with
centrifugation at 2000 rpm for 2 min between each wash
to collect beads. The washed beads were then boiled for 5
min in 1× sample buffer to elute proteins. Input proteins
were precipitated by TCA extraction before running sam-
ples on SDS-PAGE gels, with western blotting performed as
described.
DNA purification for Southern blotting
Frozen pellets were re-suspended in 0.4 ml of DNA
Extraction Buffer (50 mM Tris–HCl pH 8.0, 100
mM NaCl, 10 mM EDTA, 1% SDS) along with 40
Units of lyticase (Sigma-Aldrich, L2524) and 5 l 2-
mercaptoethanol (Sigma Aldrich, 63689). Samples were
incubated at 37◦C for 5 min before addition of 450 l
phenol/chloroform/isoamylalcohol (25:25:1, Sigma-
Aldrich) and mixing by rotation. Phase lock tubes (5
Prime, 2302800) were used to collect the aqueous layer, by
centrifugation for 5 min at 12 000 rpm. DNA was ethanol
precipitated by addition of roughly 2× volume of 100%
EtOH and washed once in 70% EtOH before air-drying
and solubilisation in 10 mM Tris pH 8.0.
For plasmid DNA catenation analysis of pRS316, puri-
fied DNA was nicked with Nb.Bsm1 (New England Biolabs,
R0706S) according to manufacturer’s instructions.
For fork pausing analysis of pRS426-RFB, purified DNA
was digested with BamHI-HF (New England Biolabs,
R3136S) and SnaBI (New England Biolabs, R0130L) or
SnaBI alone according to manufacturer’s instructions.
After nicking/digestion the DNA was precipitated,
washed and solubilised as above with the addition of 300
mM Sodium Acetate pH 5.2 at the first ethanol addition.
2D gel electrophoresis of replication intermediates or cate-
nated plasmid replication products
Purified DNA was separated in the first dimension by elec-
trophoresis in 0.4% MegaSieve/MegaBase Agarose (Scien-
tific Laboratory Supplies, H15608), 1× TBE (90 mM Tris,
90 mM boric acid, 10 mM EDTA).
For DNA catenation analysis of plasmid pRS316 from
top2–4 cells, first dimension gels were run at room tempera-
ture for 16–18 h at 30 V. A lane of the gel containing a small
amount of each DNA sample was excised and stained in 0.5
g/ml Ethidium Bromide 1× TBE to reveal extent of ge-
nomic DNA mobility. The remaining non-stained gel slices
containing the plasmid were excised and embedded in 1.2%
MegaSieve/MegaBase Agarose 1X TBE and run in the sec-
ond dimension in 1× TBE at 4◦C for 16–17 h, 120 V.
For analysis of paused replication intermediates from
plasmid pRS426-RFB, first dimension gels were run at
room temperature for 15.5 h at 30 V. First dimension gels
were stained in 0.5 g/ml Ethidium Bromide in 1× TBE
and gel slices containing the replication intermediates
were excised and embedded in 1% MegaSieve/MegaBase
Agarose 1× TBE 0.3 g/ml Ethidium bromide gels. Second
dimension gels were run in 1× TBE at 4◦C for 8 h, 120 V
with re-circulation of the running buffer.
Southern blotting
Following 2D electrophoresis, gels were washed sequen-
tially in depurination buffer (0.125 M HCl), denatura-
tion buffer (0.5 M NaOH, 1.5 M NaCl) and neutralisa-
tion buffer (0.5 M Tris–HCl, 1.5 M NaCl pH 7.5) with
washes in ddH2O in-between each buffer. DNA was trans-
ferred onto Hybond-N+ membrane (GE Healthcare) by
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trisodium citrate pH 7.0). Membranes were cross-linked us-
ing a UV Stratalinker 1800 (Stratagene) at 1200 J/m and
subsequently blocked in hybridisation buffer (5× SSC, 5%
Dextran sulphate (Sigma-Aldrich, D8906) 0.2% Tropix I-
Block (Applied Biosystems, T2015), 0.1% SDS) for at least
1 h at 60◦C.
Catenated pRS316 plasmids or replication intermediates
from pRS426-RFB were probed with DNA amplified from
pRS316 (probing specifically for the URA3 gene). Labelling
and detection used random prime labelling incorporating
fluorescein tagged dUTP (Roche). Following probing, hy-
bridized fluorescein tagged dUTP was detected with al-
kaline phosphatase tagged anti fluorescein Fab fragments
(Roche), revealed with CDP-Star (GE Healthcare) and non-
saturating exposures acquired on an ImageQuant LAS4000
system (GE Healthcare). Densitometry analysis was carried
out using ImageQuant TL software.
FACS analysis of DNA content
For analysis of cell cycle progression, 0.5 ml of yeast culture
was pelleted by centrifugation at 13 000 rpm for 15 s before
removal of all growth media. The pellets were re-suspended
in 0.5 ml 70% ethanol and stored at 4◦C before processing
and analysis.
Fixed cells were washed in 50 mM Tris pH 8.0 and 10
mg/ml RNaseA (Sigma-Aldrich) was added. Cells were in-
cubated overnight at 37◦C, pelleted and re-suspended in
freshly made 5 mg/ml pepsin (Sigma) in 5 mM HCl and in-
cubated again at 37◦C for 30 min. Fixed cells were washed
once more in 50 mM Tris pH 8.0 and re-suspended in 0.5
mg/ml propidium iodide in 50 mM Tris pH 8.0. Samples
were sonicated for 5 s each on low power to reduce clump-
ing before analysis using the BD Accuri™ C6 Plus (BD Bio-
sciences).
Drug sensitivity assays
Yeast cells were grown to mid-log phase before being seri-
ally diluted 10-fold in YPD. 5 l of each dilution was spot-
ted onto YPD plates containing the indicated dose of drug
or control reagent and incubated for 48 h at 25◦C or 30◦C
before imaging.
Colony survival assays
Yeast cells were grown to mid-log phase before being ar-
rested in G1 by the addition of 10 g/ml alpha factor pep-
tide. When cells were >90% unbudded they were released
into the cell cycle in the presence of 200 mM HU for 1 h.
Following the HU treatment cells were counted, diluted in
YPD medium and plated onto YPD plates. Colonies were
counted 48 h after plating and the viability was calculated as
the percentage of plated cells able to form colonies. Statisti-
cal significance was calculated using a two-tailed unpaired
Students t-test.
RPA1 ChIP-seq
Pellets from 75 ml cultures were resuspended in 500 l SDS
buffer (1% SDS, 10 mM EDTA, 5M Tris HCl, cOmplete
Tablets Mini EDTA-free EASYpack (Roche), PhosSTOP
(Roche)). 200 l of 0.5 mm zirconia/silica beads were added
to samples and cells were lysed using the FastPrep-24 (MP
Biomedicals) on max speed (6.5 m/s), with five rounds
of 1 min each. Lysate was spun out and IP buffer (0.1%
SDS, 1.1% Triton-X-100, 1.2 mM EDTA, 16.7 mM Tris–
HCl (pH8), cOmplete Tablets Mini EDTA-free EASYpack
(Roche), PhosSTOP (Roche)) was added to a final vol-
ume of 1 ml. Samples were sonicated using the Focused-
Ultrasonicator (Covaris) (average incident power 7.5 W,
peak incident power 75 W, duty factor 10%, cycles/burst
200, duration 20 min). The sample was centrifuged for 20
min at 13 000 rpm at 4◦C. Supernatant was then diluted to
7.5 ml with IP buffer. 75 l protein A Dynabeads (Invit-
rogen) and 75 l protein G Dynabeads (Invitrogen), were
washed 3 times in IP buffer before adding to the sample and
incubating for 2 h at 4◦C. 2 ml of the supernatant was taken
to 15 ml falcon tubes, and the rest was kept at −20◦C as an
input sample. To the 2 ml sample RPA1 antibody (1:10 000,
Agrisera, AS07214) was added followed by overnight incu-
bation on a rotating wheel at 4◦C.
A mix of Dynabeads, Protein A (30 l) and Protein G
(30 l), was washed 3 times in IP buffer. This was added
to each sample and incubated at 4◦C for 4 h. Supernatant
was removed and beads were washed at 4◦C for 6 min in
TSE-150 (1% Triton-X-100, 0.1% SDS, 2 mM EDTA, 20
mM Tris–HCl (pH8), 150 mM NaCl), followed by TSE-500
(1% Triton-X-100, 0.1% SDS, 2 mM EDTA, 20 mM Tris–
HCl (pH8), 500 mM NaCl), followed by LiCl wash (0.25 M
LiCl, 1% NP-40, 1% dioxycholate, 1 mM EDTA, 10 mM
Tris–HCl (pH8)) and finally Tris-EDTA (TE pH8). Elution
was carried out in 400 l elution buffer (1% SDS, 0.1M
NaHCO3) for 30 min at room temperature. At the same time
50 l from the input sample was added to 150 l of elu-
tion buffer. 20 l of 5 M NaCl and 10 l of 10 mg/ml pro-
teinase K (Invitrogen) was then added to the input, and 40
l and 20 l to the IP samples respectively. These were incu-
bated at 65◦C overnight. Then 10 l of DNase-free RNase
(Roche) was added to the input and 20 l to the IP samples,
and they were left at 37◦C for 30 min. All DNA was puri-
fied with a Qiagen PCR purification kit and eluted in 40 l
H2O. 34 l from the RPA1 samples and 1 ng DNA in 34
l water from the input were used for library preparation.
5 l 10× NEB2.1 buffer and 5 l of random primers (8N,
3 mg/ml stock) were added and the samples were boiled at
95◦C for 5 min and immediately placed on ice for 5 min. 5
l 10× dNTPs with dUTP instead of dTTP (2 mM each)
and 1 l T4 polymerase (NEB) were added and the mixture
was incubated at 37◦C in a thermal cycler for 20 min, and 5
l 0.5 M EDTA (pH 8) was immediately added to stop the
reaction. The resulting dsDNA was used to create libraries
using the Ultra II library kit (NEB) as per the manufac-
turer’s instructions with 13 cycles at the amplification step.
Paired end sequencing was performed using the MySeq
(75 bp reads from each side) or NextSeq 500 (42 bp reads
from each side) systems to result >2 million reads.
ChIP-SEQ analysis
FASTQ files were generated by Illumina basespace (https:
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quences were aligned to a reference genome (R64–1-1, Sac-
charomyces cerevisiae S288c assembly from Saccharomyces
Genome Database) using Bowtie 2 generating a SAM out-
put file for each sample (http://bowtie-bio.sourceforge.net/
bowtie2/index.shtml). Reads from MySeq were trimmed 25
bp from 3′ and 1 bp from the 5′ end, while reads from
NextSeq were not trimmed.
Command for MySeq reads:
bowtie2 -p 14 -x [path to index folder]
--trim3 25 --trim5 1 -1 [Path and name
of R1 fastq file] -2 [Path and name of
R2 fastq file] -S [name of the resulting
.sam file]
Command for NextSeq reads:
bowtie2 -p 14 -x [path to index folder]
--trim3 0 --trim5 0 -1 [Path and name
of R1 fastq file] -2 [Path and name of
R2 fastq file] -S [name of the resulting
.sam file]
SAM files were then converted into sorted BAM files by
using SAMtools (http://samtools.sourceforge.net/):
samtools sort [name of the .sam file
generated with bowtie2] -o [name for the
resulting .bam file] -O bam -T [name for
resulting .bam file wo .bam]
Duplicates were then removed using picard (https://
broadinstitute.github.io/picard)
java -jar ∼/picard/picard-tools-
1.138/picard.jar MarkDuplicates I = [name
for the resulting .bam file] O = [name
for the resulting without repeats.bam
file] M = [name of metrix file.txt] RE-
MOVE DUPLICATES = true
BAM files were used for Model-based Analysis of ChIP-
Seq (MACS2). We used the ‘call peak’ function which also
generates genome wide score data. These were used to gen-
erate fold enrichment tracks. Example command:
macs2 callpeak -t [sorted BAM file from
yh2a data]-c [sorted BAM file from h2a
data]-f BAMPE -g 12100000 -n [name for
output file] -B -q 0.01 --SPMR
The data then was sorted into 50 bp bins, normalized to
have a mean value of 1, and used for meta data analysis us-
ing custom-made R programs.
Regions within 10 kb of LTR-retrotransposons, trans-
posable element genes, rRNA genes and long terminal re-
peats were removed from the meta analysis as these regions
have high RPA enrichment.
Sync-seq
Pellets from 2 ml cultures were resuspended in 500 l SDS
buffer (1% SDS, 10 mM EDTA, 5 M Tris–HCl, cOmplete
Tablets Mini EDTA-free EASYpack (Roche), PhosSTOP
(Roche)). 200 l of 0.5 mm zirconia/silica beads were added
to samples and cells were lysed using the FastPrep-24 (MP
Biomedicals) on max speed (6.5 m/s), with five rounds
of 1 min each. Lysate was spun out and IP buffer (0.1%
SDS, 1.1% Triton-X-100, 1.2 mM EDTA, 16.7 mM Tris–
HCl (pH8), cOmplete Tablets Mini EDTA-free EASYpack
(Roche), PhosSTOP (Roche)) was added to a final vol-
ume of 1 ml. Samples were sonicated using the Focused-
Ultrasonicator (Covaris) (average incident power 7.5 W,
peak incident power 75 W, duty factor 10%, cycles/burst
200, duration 20 min for G1 and HU released samples and
13.5 for HU samples). 200 l of sample was removed and 10
l of DNase-free RNase was added and incubated at 37◦C
for 30 min. DNA was then purified with a Qiagen PCR pu-
rification kit and eluted in 50 l H2O. 50 ng of DNA in 50
ul water was used for library preparation using the Ultra
II library kit (NEB) as per the manufacturer’s instructions
with 6 cycles at the amplification step.
Paired end sequencing was performed using NextSeq 500
(42 bp reads from each side) systems to result >2 million
reads.
Sync-seq analysis
Sync-seq analysis (29) was carried out using LocalMapper
shell script and Repliscope R package from https://github.
com/DNAReplicationLab/.
localMapper.sh -g [path to index folder] [Path and name
of R1 fastq file] -2 [Path and name of R2 fastq file] -s [name
of the output files] -w 3000 -c 14
The resulting .bed files were then read in to R:
repBed ← loadBed(file name for the replicating sample)
nrepBed ← loadBed(file name for the non-replicating sam-
ple)
Outliers were removed:
repBed←rmOutliers(repBed, ‘median’, loLim = 0.25)
repBed←rmOutliers(repBed, ‘max’, n = 2)
nrepBed←rmOutliers(nrepBed, ‘median’, loLim = 0.25)
nrepBed←rmOutliers(nrepBed, ‘max’, n = 2)




ratio ← normaliseRatio(ratio, [rFactor])
where rFactor was empirically determined to fit the low-
est replicating regions to 1.
The resulting ratios were smoothed by a moving average
of 7 and plotted using custom-made R programs.
RESULTS
Tof1 mutants lacking Top1 binding capability cannot sup-
press replication fork hyper-rotation
In order to dissect which domains of the 1238 amino acid
(aa) long Tof1 protein are required for each of its charac-
terised functions we generated a series of premature stop
codons in a TOF1 ORF sequence optimised for budding
yeast expression (12). Premature stop codons were intro-
duced at aa 627, aa 762, aa 830, aa 997 and aa 1182 (Figure
1A) and the truncated alleles expressed from the endoge-
nous TOF1 locus. C terminal tagging of each of these al-
leles demonstrated that they generated proteins of the pre-
dicted full-length size, which were expressed to levels com-
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Figure 1. Expression of C terminal Tof1 truncation mutations. (A)
Schematic showing length of Tof1 protein expressed by each of the C
terminal truncation mutations compared to wildtype Tof1 (1238 aa). (B)
Western blot showing expression levels of C terminal Tof1 truncation
mutants. Endogenous TOF1 (TOF1 wt), codon-optimised TOF1 (TOF1)
and tof1 mutants were C terminally tagged with TAP epitope and lysates
were checked for expression using peroxidase anti-peroxidase (PAP) which
immuno-reacts with the protein A portion of TAP tags. Ponceau stain of
blotted membrane is shown to illustrate protein content of lanes. A repre-
sentative western of the two experiments performed is shown.
TOF1 and endogenous TOF1 (Figure 1B). We noted that
both TOF1 and mutated tof1 C terminally tagged alleles
also generated a faster mobility form of protein, in addition
to the predicted full-length protein (Figure 1B). The size dif-
ference between these two forms appeared to be the same for
both the full-length and truncation alleles, suggesting that
the difference was due to a modification in the N terminal
half of the protein. To investigate this further we tagged the
N terminus of TOF1, tof1 627, tof1 997 and tof1 1182 with
the HA epitope and re-examined expression (Supplemen-
tary Figure S1). We only observed the full-length protein
in this case, indicating that the faster mobility form of Tof1
lacks the beginning of the N terminus of the full-length pro-
tein. Since both the full length and N terminal variant of the
wildtype and truncated proteins are altered by the same C
terminal truncations, we continued with our analysis of the
requirement of C terminal regions for function.
To understand how truncation of the C terminus affects
Tof1 function, we first set out to establish which of the
truncated Tof1 proteins could suppress the excessive fork
rotation phenotype of tof1Δ cells, as visualised by South-
ern blotting of replication products (22). In cells with wild-
type function of TOF1, episomal plasmids accumulate only
modest levels of DNA catenanes during S phase following
Top2 inactivation (Figure 2A). This demonstrates that fork
rotation is relatively infrequent and therefore that DNA
topological stress is primarily resolved by Top1 ahead of the
replication fork in this context (22). In contrast, tof1Δ cells
accumulate hyper-catenated plasmids during S phase indi-
cating that, in cells lacking Tof1, DNA topological stress
is resolved far more frequently by fork rotation and action
of topoisomerase behind the fork (Figure 2B). To assess
whether the truncated proteins were capable of suppressing
hyper-catenation and thus restoring the primacy of Top1 ac-
tion ahead of the fork, we replaced TOF1 with each of the
tof1 truncation alleles encoding the truncated proteins into
top2–4 cells containing the plasmid pRS316. Following syn-
chronisation in G1, we cultured the cells at the restrictive
temperature to ablate Top2 activity and released the cells
into the cell cycle for one passage through S phase. We then
harvested the cells prior to mitosis, preventing further cell
cycle progression with the microtubule depolymerising drug
nocodazole. We extracted DNA and assessed the frequency
of DNA catenation introduced into the plasmid using two-
dimensional gel electrophoresis and Southern blotting. As
expected, expression of TOF1 completely suppressed exces-
sive fork rotation and DNA catenation (Figure 2C). Ex-
pression of tof1 1182 which lacks only the final 57 amino
acids of the C terminus of Tof1 also fully rescued the exces-
sive fork rotation (Figure 2H). However, expression of Tof1
proteins truncated at 627, 762, 830 and 997 did not rescue
this effect (Figure 2D-G). This indicates that the region of
Tof1 between aa 997 and aa 1182 is required to suppress
excessive fork rotation. This region is known to be capa-
ble of supporting a two-hybrid interaction with Top1 (23)
and is required to recruit Top1 to the replication fork (24).
To certify that the interaction between Tof1 and Top1 re-
quires the region between aa 997 and aa 1182, we pulled
down C terminally TAP tagged tof1 truncation proteins and
probed for interaction with myc tagged Top1 protein. This
analysis confirmed that TAP tagged tof1 1182 protein could
pull down myc tagged Top1 in cells (Supplementary Fig-
ure S2). In contrast, TAP tagged tof1 627 and 997 proteins
did not (Supplementary Figure S2). This is consistent with
the model that preferential recruitment of Top1 to the repli-
some stimulates its action ahead of the fork (3,22).
The fork pausing function of Tof1 is separate from its role in
topological stress
We next set out to determine which of the mutants were
able to support replication fork pausing at a replication
block. We cloned the S. cerevisiae rDNA region that con-
tains the replication fork barrier (RFB) (corresponding to
Chromosome XII sequence: 459799–460920) into the mul-
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Figure 2. Suppression of hyper-catenation on episomal plasmids in Top2-inactivated cells requires the far C terminal region of Tof1. (A) Plasmid pRS316
used for DNA catenation analysis. (B) Schematic showing the representative increase in DNA catenation of plasmid pRS316 in tof1Δ top2–4 cells compared
to top2–4 cells as visualized by Southern blotting. Region of hypercatenated plasmids highlighted in red box. (C-H) DNA catenation analysis of pRS316
in top2–4 cells expressing (C) TOF1 (D) tof1 627 (E) tof1 762 (F) tof1 830 (G) tof1 997 (H) tof1 1182 Images shown are from one of two equivalent
independently conducted experiments.
planting the RFB sequence into an artificial location pauses
replication forks in a Fob1 dependent manner but does not
fully arrest ongoing replication (20). It therefore appears to
act in a similar manner to other endogenous protein paus-
ing sites (21). We used both a BamHI/SnaBI double diges-
tion of plasmid pRS426-RFB extracted from yeast cells to
examine Y arcs containing the RFB (cartoon of replication
intermediates revealed shown in Figure 3B) (Figure 3C–I)
or SnaBI single digestion to examine the replication inter-
mediates of the entire replicon (Supplementary Figure S3)
(30). We found that cells without Tof1 did not pause at the
RFB site on the plasmid (Figure 3C, Supplementary Figure
S3B), whereas cells expressing TOF1 fully supported paus-
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YPD + DMSO YPD + 20μM CPT
Figure 3. Recovery of fork pausing and resistance to camptothecin requires the central region of Tof1 but not the far C terminal region. (A) Plasmid
pRS426-RFB used for analysis of fork pausing at the RFB. The two unique restriction digest sites used to linearize the plasmid for 2D replication fork
gel analysis and the Y structure anticipated to be generated by fork pausing at the RFB pause site are shown. (B) Schematic of the replication fork Y arc
predicted to be generated by pRS426-RFB digestion with BamHI and SnaBI in wildtype cells and resolved by 2D gel electrophoresis. Arrow indicates
the accumulation of replication intermediates generated by pausing at the RFB on pRS426-RFB. (C–I) 2D gel analysis of BamHI and SnaBI digested
pRS426-RFB extracted from exponentially growing cells containing (C) tof1Δ (D) TOF1 (E) tof1 627 (F) tof1 762 (G) tof1 830 (H) tof1 997 (I) tof1 1182
(J) Viability spot assay of wildtype (wt), tof1Δ, TOF1, tof1 627, tof1 762, tof1 830, tof1 997, and tof1 1182 cells. Cells were spotted in ten-fold sequential
dilutions on either YPD + DMSO or YPD plus 20 M camptothecin (CPT) plates and incubated for 48 h at 25◦C. Images shown are from one of two
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Expression of tof1 830, tof1 997 and tof1 1182 also fully sup-
ported pausing (Figure 3G–I, Supplementary Figure S3F-
H). However, expression of tof1 627 and tof1 762 did not
rescue pausing at the RFB site (Figures 3E and F, Supple-
mentary Figure S3D and E). Together this data indicates
that the region beyond aa 830 is not required for replication
fork pausing at protein barriers and therefore that the role
of Tof1 in replication fork pausing is independent of its role
in inhibiting fork rotation.
Deletion of TOF1 results in hypersensitivity to CPT, an
agent which stabilises the Topoisomerase 1 covalent com-
plex (Top1cc) to DNA, forming a DNA protein cross-link
(DPC). Deletion of CSM3 results in similar sensitivity to
CPT treatment while mrc1 cells display only mild sensi-
tivity to this agent (25). Therefore, CPT sensitivity appears
to be a marker for functions of the Tof1–Csm3 heterodimer
that are independent of their association with Mrc1. The
cause of the acute toxicity of tof1Δ or csm3Δ cells to CPT is
currently unclear. On the leading strand a DPC and an adja-
cent single strand DNA break would be predicted to either
inhibit replication fork progression or generate a double
strand break (31,32). Alternatively, CPT treatment has also
been found to cause increased DNA topological stress on
cellular DNA (33), potentially generating a situation where
efficient recruitment of topoisomerases to the fork by Tof1
is required for ongoing elongation. Our data shows that tof1
truncations that cannot support relaxation of DNA topo-
logical stress through Top1 recruitment can still support
fork pausing at an RFB complex. We therefore examined
how expression of each of the truncation mutations sup-
pressed the sensitivity of tof1Δ cells to CPT. Cells express-
ing tof1 627 or tof1 762 were highly sensitive to CPT while
expression of tof1 830, tof1 997 and 1182 provided wt lev-
els of resistance to CPT (Figure 3J). Therefore, truncation
mutants that do not support Tof1’s role in promoting Top1
action ahead of the fork (tof1 830 and tof1 997) have nor-
mal levels of resistance to CPT. Conversely, tof1 truncations
that do not support replication fork pausing (tof1 627 and
tof1 762) cannot suppress CPT sensitivity. We conclude that
CPT sensitivity is closely associated with the ability of the
Tof1-Csm3 complex to support pausing of the fork at a pro-
tein block to replication.
Despite our findings that the C terminal region beyond aa
830 is not required for CPT resistance, we also observed that
some mutations located C terminal of aa 830 can still impair
cellular resistance to CPT. While assessing the function of
conserved domains in the C terminus we found that an in-
ternal deletion of the region coding for aa 1050–1080 results
in impaired CPT resistance (Supplementary Figure S4A).
We conclude that although the C terminal region beyond
aa 830 is not required for CPT resistance and fork pausing,
disruption of the polypeptide structure of this region can
disrupt the function of other regions of the protein. Such a
characteristic of the C terminus could explain why another
study has found that a Tof1 protein truncated at aa 981 by
addition of a FLAG peptide tag causes CPT sensitivity and
reduced pausing at the RFB in cells (24). Potentially the ad-
dition of a peptide tag could induce a distortion in the C ter-
minal region capable of disrupting activity elsewhere in the
protein. We therefore tested the possibility that a C termi-
nal tag in this region could deleteriously affect Tof1 function
(Supplementary Figure S4B). We observed that addition of
a C terminal TAP tag to the tof1 997 protein causes a clear
increase in the CPT sensitivity of tof1 997 expressing cells.
Addition of a C terminal TAP tag did not adversely affect all
regions of the protein, as the tagged forms of TOF1 or tof1
627 did not appear to be more sensitive to CPT than their
untagged forms (Supplementary Figure S4B). Our data ar-
gues that while the polypeptide structure of the first 830 aa
is sufficient for fork pausing and CPT resistance functions
of Tof1, structural deformation in the C terminal region be-
yond this point can still alter the activity of the rest of the
protein.
The replisome coupling function of Tof1 is associated with its
role in fork pausing
Replisome pausing induced by nucleotide depletion with
hydroxyurea (HU) also requires Tof1 function. Following
acute treatment of cells with HU both Tof1 and Mrc1 are re-
quired to maintain the coupling of helicase and polymerase
activities at the fork (15). In the absence of Tof1 or Mrc1 the
helicase advances beyond the point of nascent DNA incor-
poration, indicating uncoupling of helicase and polymerase
activities in the replisome (15). This uncoupling is predicted
to lead to increased binding of the single stranded DNA-
binding protein, RPA1, to the single stranded regions gen-
erated by uncoupled helicase action. We have experimen-
tally confirmed this prediction using RPA1 ChIP-SEQ in
HU treated wildtype, tof1Δ and mrc1Δ cells. Release of cells
arrested in G1 with alpha factor into media containing 200
mM HU led to strongly increased RPA1 chromatin binding
around replication origins in tof1 and mrc1 cells com-
pared to wildtype (Figure 4A). Expression of TOF1 and
tof1 830 both suppressed the accumulation of RPA1 around
origins (Figure 4B). Thus, expression of the tof1 830 trun-
cation mutant was sufficient to ensure helicase and poly-
merase coupling. However, expression of either tof1 762 or
tof1 627 still led to increased RPA1 around origins, indicat-
ing uncoupling of helicase and polymerase activities. No-
tably the elevated level of RPA1 around origins in either tof1
762 or tof1 627 was less than the level of RPA1 observed in
tof1 cells (Figure 4B), indicating that they retained some
function in coupling of helicase and polymerase activities,
potentially through their mediation activity in the DRC (see
below).
The C terminus of Tof1 beyond aa 627 is dispensable for DRC
activation and replication fork restart but required for cell vi-
ability following fork restart
We next set out to establish whether expression of the trun-
cated proteins was sufficient to support the mediator func-
tion of Tof1 in activation of the DRC. In S. cerevisiae sus-
tained activation of the effector kinase Rad53 in S phase
following HU treatment can either be through the DRC,
mediated by Mrc1 and Tof1, or through the Rad9-mediated
DDC (8). Therefore, loss of detectable activation of Rad53
in response to HU only occurs in cells lacking both tof1 and
rad9 function. Conversely, HU-dependent Rad53 activation
can be rescued by the activity of either Tof1 or Rad9 pro-
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Figure 4. Coupling of helicase and polymerase activities requires the central region of Tof1 but not the far C terminal region. To examine the extent of
fork uncoupling we assayed ChIP of RPA1 (ScRfa1) following 200 mM hydroxyurea (HU) arrest of cell proliferation. (A) Schematic of experimental set
up and meta-analysis of enrichment of RPA1 (ScRfa1) around origins in wt, tof1Δ and mrc1Δ cells following release of G1 cells into media containing
200 mM HU for 60 min. (B) Meta-analysis of enrichment of RPA1 (ScRfa1) around origins in TOF1, tof1Δ tof1 627, tof1 762 and tof1 830 cells following
release of G1 cells into media containing 200 mM HU for 60 min. Data shown is from merging two independently conducted Rfa1 ChIP-SEQ experiments
in each background.
any of the tof1 truncation mutants could rescue Rad53 ac-
tivation in response to HU treatment in tof1Δ rad9Δ cells,
using the Rad53 phospho-mobility assay (34). In these ex-
periments, treatment of exponentially growing wt cells with
200 mM HU led to a robust auto-phosphorylation-linked
mobility shift of Rad53 protein as visualised by western
blot. This shift was partially attenuated in tof1Δ and lost in
tof1Δ rad9Δ cells (Figure 5A). Interestingly, expression of
all of the truncation mutants rescued the phosphorylation-
linked mobility shift of Rad53 in response to HU (Figure
5A). Therefore, the first 627 aa of Tof1 retains the abil-
ity to act as a mediator for the DRC. Previous studies
have shown that hypo-morphic alleles of some checkpoint
components delay but do not prevent the full activation of
Rad53 following treatment with HU (35). To assess whether
this was the case for the tof1 627 allele we assayed protein
extracts from cells taken at sequential time points following
release into 200 mM HU for Rad53 activation (Figure 5B).
We did not observe a delay in activation of Rad53 in the
tof1 627 allele compared to wildtype Tof1, consistent with
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Figure 5. Following HU arrest the N terminal half of Tof1 is sufficient for DRC activation and resumption of DNA synthesis but not cell viability in
DDC deficient (rad9Δ) cells. (A) Rad53 activation assay following HU treatment. Activation of Rad53 causes autophosphorylation that results in reduced
mobility of the Rad53 protein. The relative mobility of Rad53 in each of the indicated cell types either in exponentially growing cells or following a 2 h
treatment with 200 mM HU was assayed by western blot using anti-Rad53 antibodies (top). Ponceau stained membrane of western blot shown in top
panel indicates relative protein levels (bottom). Image shown is from one of two equivalent independently conducted experiments. (B) (Top) Time course
of Rad53 activation following release from G1 into media containing 200 mM HU. (Bottom) Ponceau stained membrane of western blot shown in top
panel indicates relative protein levels. Image shown is from one of two equivalent independently conducted experiments. (C) Recovery of DNA synthesis
in cells following cell cycle arrest induced by 200 mM HU. The indicated cell mutants were arrested in 200 mM HU following release of a G1 synchronised
culture. After 60 min in HU, the HU containing media was washed off and cells allowed to recover and resume passage through S phase. Shown are FACS
profiles of DNA content before and after the HU arrest point. Time points indicate the time in minutes after release from the HU arrest (T0 indicates time
from the first wash). Images of DNA content FACS shown are from one of two equivalent independently conducted experiments. (D) Viability of cells
following cell cycle arrest induced by acute HU treatment. G1-arrested cells were released from the block into YPD media containing 200 mM HU for 60
min, after which the cultures were diluted and plated to YPD plates. Plates were incubated for 48 h at 25◦C before images were taken (top). Colony number
was counted 48 h after plating and results from 4 repeats were quantified and displayed in histogram (bottom). P values: * = <0.05, ** = <0.01, *** =
<0.001 calculated using a two-tailed unpaired Student’s t-test using four repeats for each mutant tested. (E) Viability of cells during chronic treatment with
HU. Viability spot assay of TOF1, tof1Δ, tof1 627, tof1 762, tof1 830, tof1 997 and tof1 1182 cells on YPD or YPD plus 10 or 40 mM HU for three days
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The separation of function observed between the
roles of Tof1 in checkpoint signalling and in replisome
coupling/pausing provided us with an opportunity to dif-
ferentiate between the contributions of these two Tof1 func-
tions to genome stability following RS induced replisome
stalling. Following treatment of budding yeast with 200
mM HU, replication forks stall shortly after origin firing,
activating the DRC. DRC activation is essential to main-
tain cellular viability during incubation in HU (36,37).
Checkpoint-dependent viability is thought to be due to reg-
ulation of several pathways including inhibition of late ori-
gin firing (38), inhibition of nucleases that could process the
arrested fork (39,40) and stabilisation of replisome com-
ponents at the arrested fork (36,37). The role of Tof1 in
maintaining genome stability in response to RS could either
be through mediation of checkpoint signalling or through
its pausing/coupling activities aiding maintenance of repli-
some integrity, or a combination of the two. To investigate
the contribution of these two roles to genome stability we
compared the response to arrest and subsequent wash off
of 200 mM HU in tof1 rad9 cells, where the checkpoint
activation of Rad53 is ablated, to tof1 rad9 cells com-
plemented with either TOF1, tof1 627 or tof1 830, all of
which generate Tof1 protein capable of activating the DRC
in tof1 rad9 cells (Figure 5C and 5D). Using FACS anal-
ysis of DNA content, we observed that uncomplemented
tof1 rad9 cells were unable to complete DNA replica-
tion following removal of 200 mM HU, consistent with pre-
vious analysis of checkpoint-defective cells (36,41) (Figure
5C). Complementation of these cells with wildtype Tof1 re-
sulted in rapid completion of DNA replication (Figure 5C).
In addition, complementation of tof1 rad9 cells with ei-
ther of the checkpoint competent truncation mutants tof1
627 or tof1 830 also resulted in rapid apparent comple-
tion of DNA replication (Figure 5C), consistent with the
checkpoint function of Tof1 alone being sufficient for re-
sumption of DNA replication following HU arrest. In ad-
dition to testing DNA content we also re-plated these cells
following release from the acute HU treatment onto YPD
plates to assess whether they could survive the treatment.
As expected, tof1 rad9 cells failed to form colonies fol-
lowing acute HU treatment whereas TOF1 rad9Δ cells dis-
played efficient colony-forming capability (Figure 5D). De-
spite their apparent resumption in DNA replication follow-
ing acute HU treatment, tof1 627 cells generally failed to
recover from the HU-induced arrest, although they were
significantly more viable than tof1 rad9 cells (Figure
5D). This indicates that despite DRC activation and appar-
ent efficient resumption of DNA replication, tof1 627 ex-
pressing cells were still subject to frequent unrecoverable le-
sions following fork stalling. Consistent with this interpre-
tation both tof1 627 and tof1 762 cells were acutely sensi-
tive to chronic treatment with HU compared to the other
tof1 truncation mutants in rad9 cells (Figure 5E). This in-
dicates that Tof1 has roles in maintaining cellular viability
during replication stress beyond activation of the DRC and
resumption of DNA replication.
FACS analysis of DNA content cannot distinguish if any
increases in DNA content are due to restart of arrested
replication forks or due to new origins firing. To investi-
gate this issue, we carried out sync-seq analysis (41,42) to
compare copy number differences across the genome be-
tween cells arrested in 200 mM HU and cells 80 minutes fol-
lowing wash off of HU, recovery and resumption of DNA
replication (Figure 6A). Analysis of TOF1 rad9Δ, tof1 627
rad9Δ, tof1 830 rad9Δ and tof1Δ rad9Δ cells arrested in HU
all showed similar copy number in the immediate vicinity
of early firing origins as expected (Figure 6B left). Further
sync-seq analysis of the same cultures 80 minutes after HU
removal showed that TOF1 rad9 and tof1 830 rad9 cells
had completed replication around origins fired before HU
arrest as anticipated, indicating that stalled forks in these
cells were able to restart replication following release from
the HU block (Figure 6B top right). As predicted, tof1Δ
rad9Δ cells had a much smaller increase in copy number
around origins consistent with poor levels of recovery or
restart from HU-arrested forks in this genetic background
(Figure 6B right). In contrast to these two extremes, tof1
627 cells exhibited a similar pattern of increased copy num-
ber around origins fired in HU to wt and tof1 830, but of-
ten failed to increase copy number to the same level in later
replicating regions (Figure 6B bottom right). As sync-seq
assays a population of cells, we cannot exclude that the ob-
served increased in copy number around origins in tof1 627
cells, following washout of HU, is due to firing of adjacent
dormant origins rather than fork restart. However, we note
that copy number increases are usually similar on both sides
of early origins following resumption suggesting fork restart
rather than dormant origin firing as the cause of increased
copy number.
These findings indicate that Tof1 proteins that can me-
diate DRC activation can promote efficient restart around
HU-stalled forks. However, replication forks associated
with Tof1 proteins that cannot support replisome coupling
or pausing then go on to exhibit elongation defects that of-
ten prevent the completion of DNA replication. This leads
to toxic lesions if Rad9-dependent repair pathways are ab-
sent.
The fork pausing and replisome coupling functions of Tof1
are linked to its stable interaction with Csm3
In summary, we have found that the function of Tof1 in
checkpoint activation only requires the N terminal half of
the Tof1 protein. In contrast the roles of Tof1 in supporting
fork pausing, suppressing CPT sensitivity, coupling of heli-
case and polymerase activities and maintaining fork stabil-
ity following RS all require aa 627–830 of Tof1. The region
beyond aa 997 is necessary for Tof1’s role in resolving DNA
topological stress ahead of the fork, but is not required
for pausing, coupling or resistance to CPT. Recent struc-
tural analysis has indicated that the prime interacting in-
terface between Tof1 and Csm3 is within the 627–830 aa of
Tof1 (42,43). Therefore, loss of amino acids 627–830 of Tof1
could destabilise the interaction between Tof1 and Csm3.
We assessed the stability of the Tof1-Csm3 interaction by
immunoprecipitation of TAP-tagged Tof1 truncation pro-
teins and western blotting for Csm3 (Figure 7A). We ob-
served robust interaction between Tof1 and Csm3 in TOF1,
tof1 830, tof1 997 and tof1 1182 expressing cells. In contrast
we were unable to detect a stable interaction between Tof1
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Figure 6. Replication in tof1 627 cells is reduced after release from HU treatment in rad9Δ background. (A) Experimental set up for sync-seq experiments in
cells arrested in 200 mM HU and released to follow replication fork restart. (B) Overlaid relative copy number of TOF1 rad9Δ and tof1Δ rad9Δ compared
to tof1 830 rad9Δ (top panels) and tof1 627 (lower panels) after 60 min exposure to 200 mM HU (left panels) and 80 min after wash off of HU allowing the
cells to recover and resume DNA replication (right panels). Dashed lines represent known origins. Data from one of two independent sync-seq experiments
is shown as representative of both replicates.
have shown that loss of Tof1/Timeless family proteins leads
to a decrease in the detectable level of Csm3/Tipin protein
suggesting that the interaction between the two is required
for Csm3/Tipin stability in cells (16,44). To assess for loss of
Csm3 protein, we western blotted for Csm3 in input extracts
of cells expressing WT and truncated Tof1 proteins (Figure
7A). Expression of TOF1, tof1 830, tof1 997 and tof1 1182
all supported normal levels of Csm3 protein. Notably ex-
pression of tof1 627 and tof1 762 led to partially reduced
levels of Csm3 in cells (Figure 7A). This is consistent with
the tof1 627 and tof1 762 truncations compromising the sta-
bility of the interaction between Tof1 and Csm3, leading to
partial destabilisation of the Csm3 protein.
Csm3 activity is not necessary for DRC checkpoint signalling
Our phenotypic analysis of the tof1 627 and tof1 762 trun-
cations predicts that the Tof1-Csm3 interaction is not essen-
tial for DRC activation, since both mutations are proficient
for activation but do not stably interact with Csm3. To test
this prediction, we compared the level of DRC activation
in tof1Δ rad9Δ, tof1 627 rad9Δ and csm3Δ rad9Δ cells by
visualisation of Rad53 phosphorylation in these cells fol-
lowing acute HU treatment. We observed that Csm3 is not
required for DRC activation in rad9Δ cells, as csm3Δ rad9Δ
cells were significantly more proficient in mediating Rad53
phosphorylation than tof1Δ rad9Δ cells (Figure 7B). We
did note a likely reduction in activation compared to cells
expressing TOF1 and tof1 627 (P = 0.10 and 0.13 respec-
tively). We conclude that Csm3 is not essential for DRC ac-
tivation but that its presence likely stabilises the DRC pro-
ficient conformation of the replisome.
DISCUSSION
Defining how the Timeless protein functions to maintain
genome stability, both generally and following RS has been
complicated by its multiple functions. Here we have shown
that distinct regions of Tof1 are required for its roles during
DNA replication.
We find that the far C terminal region (>997aa) of Tof1
is required to suppress excessive fork rotation in cells. This
region is also sufficient to mediate a two-hybrid interac-
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Figure 7. Amino acids 627–830 of Tof1 are required for its stable association with Csm3. (A) Pulldown of Csm3 in TAP-tagged Tof1 truncation mutants.
Lysates from exponentially growing cells containing the indicated C terminally TAP-tagged tof1 truncation proteins, were immunoprecipitated and the
resulting eluates were western blotted using antibodies to Csm3. Ponceau stain of blotted membrane of the input is shown to illustrate protein content of
lanes. Image shown is from one of two equivalent independently conducted experiments. (B) The relative mobility of Rad53 in each of the indicated cell
types either in exponentially growing cells or following a 2 h treatment with 200 mM HU was assayed by western blot using anti-Rad53 antibodies (upper
panel). Ponceau stained membrane of western blot shown in top panel to indicate relative protein levels (middle). The ratio of lower mobility modified
Rad53 versus unmodified Rad53 was quantitated from three separate experiments by densitometry of their chemiluminescence. Western blot shown is from
one of the three equivalent, independently conducted experiments and the average ratio and standard deviation of the mean are plotted in the histogram
(bottom). 200mM refers to concentration of hydroxyurea in the culture. TOF1 rad9Δ, tof1 627 rad9Δ and csm3Δ rad9Δ all generated significantly higher
ratios of modified to unmodified Rad53 in response to HU than tof1Δ rad9Δ (P values: * = <0.05). The apparently lower ratio of Rad53 activation of
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quired for the in vivo interaction of Tof1 and Top1 (24) (this
study). During DNA replication Top1 can only act ahead of
the replication fork to facilitate unwinding of the parental
DNA duplex (3,22). Therefore, the recruitment of Top1 to
the replisome via the C terminal region of Tof1 will bias
topoisomerase action to the region ahead of the fork. This
accounts for the requirement of this region to suppress the
alternate pathway of duplex DNA unwinding, specifically
fork rotation and the action of Type II topoisomerase be-
hind the fork. During preparation of this study others have
also shown that a similar C terminal region of Tof1 is re-
quired to recruit Top1 to active replication forks, consis-
tent with this model (24). Interestingly, the SV40 T anti-
gen helicase also directly recruits Top1 to the SV40 repli-
some to facilitate DNA unwinding (45) suggesting that di-
rect replisome recruitment of Top1 could be a general fea-
ture of eukaryotic replisomes. It remains to be seen if topoi-
somerase recruitment to the eukaryotic replisome is nor-
mally achieved via Timeless family proteins or if this func-
tion could be swapped between different replisome compo-
nents in different organisms.
Distinct from the far C terminus, the region of Tof1 be-
tween amino acids 627 and 830 is required for fork pausing
at the RFB protein barrier and also to maintain coupling
of helicase and polymerase activities during HU induced
RS. Expression of tof1 627 and tof1 762 truncations ablates
the interaction between Tof1 and Csm3, consistent with re-
cent structural analyses of this heterodimer (42,43). Loss of
this region appears to be linked to a general reduction of
Csm3 protein levels in cells, suggesting that the interaction
is required to stabilise Csm3 in cells. We speculate that the
Tof1–Csm3 heterodimer plays a central role in replisome
structure that facilitates coordination of CMG and replica-
tive polymerases consistent with observations across several
systems (14,15,17). Current data argues that functional con-
sequences of the Tof1–Csm3 interaction extend beyond the
mapped 627–830 aa region of Tof1. For example, we have
previously shown that csm3Δ cells do not suppress excessive
fork rotation, despite full length Tof1 still being expressed
(22). Loss of Csm3 also reduces the association of Mrc1
with the replication fork (16). This argues that the Tof1–
Csm3 interaction is required to appropriately configure the
Mrc1–Tof1 and Tof1–Top1 interactions within the repli-
some. The Csm3 interacting region of Tof1 is also required
to suppress the sensitivity of tof1Δ cells to the Top1cc com-
plexes generated by CPT. Since the C terminal region re-
quired for the Tof1–Top1 interaction is dispensable for CPT
resistance, it appears that the coordination of Top1 action
with the replisome by Tof1 is dispensable for normal cellu-
lar responses to CPT. Rather our data argue that CPT sensi-
tivity is closely linked with stable fork pausing and helicase-
polymerase coupling. We speculate that Tof1 activity allows
the fork to pause when encountering a Top1cc complex on
the leading strand, preventing polymerase runoff and the
generation of a potentially lethal single ended DNA DSB
(31).
While our data show that the C terminal region beyond
aa 830 is not required for fork pausing, coupling and re-
sistance to CPT, we have also found that disruption of the
polypeptide structure beyond aa 830 can affect these func-
tions. Further work is required to investigate if this effect is
pathological or indicative of a regulatory function for the
C terminus. Whatever the exact nature of this effect, it does
provide an explanation of the difference between the pheno-
types we describe here and those described for C terminally
tagged Tof1 proteins truncated at aa 981 (24).
Finally, we find that the N-terminal half (627 aa) of Tof1
is sufficient for intra-S-checkpoint signalling in response
to HU as assayed by the Rad53 phospho-shift assay. Both
Mrc1 and Tof1 are required for efficient checkpoint sig-
nalling in HU (9,10). In many eukaryotic systems, depletion
of Tipin also ablates DRC signalling (17,44). Here, we show
that neither the stable interaction of Tof1-Csm3, nor even
the presence of any cellular Csm3, is necessary for DRC
signalling. We speculate that this difference is due to the
different levels of Tof1/Timeless protein expressed in cells
following loss of Csm3/Tipin in different organisms. Tof1
protein is apparently stable in S. cerevisiae in the absence of
Csm3 (16) whereas in other systems loss of Tipin results in
co-depletion of Timeless protein (17,44). During DRC ac-
tivation the N terminal half of Tof1 could either have a di-
rect role in promoting Rad53 activation or an indirect role
in DRC activation by appropriately orientating Mrc1 in the
replisome. Since Mrc1 alone appears capable of facilitating
the sensor/effector kinase interaction (46), and Tof1 is re-
quired to promote association of Mrc1 with the replisome
(12,16), we favour the later scenario and we speculate that
the N terminal half of Tof1 is required to functionally ori-
entate Mrc1 at the replication fork to promote DRC acti-
vation. Consistent with this model, cryo-EM modelling of
the replisome indicates that the interface between Tof1 and
Mrc1 occurs across the N terminal half of Tof1 (42). Since
complete loss of Csm3 likely leads to some reduction in the
phospho-shift of Rad53 protein, our results suggest that
Csm3 has a role in stabilising the N terminal Tof1 depen-
dent, DRC signalling competent, replisome conformation
of Mrc1. This would be consistent with loss of Csm3 caus-
ing reduced chromatin association of Mrc1 in ChIP assays
(16).
DRC activity following fork stalling ensures that the
replisome and fork structure is maintained in a form capa-
ble of efficiently restarting. Tof1’s role as a mediator pro-
tein has provided a straightforward explanation as to why
its absence results in problems in fork restart (11). However,
the general replisome instability of tof1Δ cells also suggests
that the replisome structure formed in the absence of Tof1
may not be proficient in replication following restart after
RS. The phenotype of the separation of function mutation
tof1 627, which is proficient for checkpoint signalling but
not proficient for replisome coupling or fork pausing, in-
dicates that Tof1 has important roles in completing DNA
replication following RS beyond purely mediating DRC ac-
tivation. Although TOF1 and tof1 627 cells appear to have
equivalent levels of Rad53 mobility shift, we cannot exclude
the possibility that the cellular activity of the DRC may be
different in the two conditions. Nevertheless, our data ar-
gues that Tof1 functions separate from DRC activation are
required to stabilise replication forks following resumption
of DNA replication after RS. The reason for fork failure
following resumption of DNA replication is unclear but we
speculate that tof1 mutants deficient in coupling helicase
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recoupling during recovery from HU treatment, leading to
frequent fork failure during elongation. Notably, the sensi-
tivity of tof1 mutants to HU is highly dependent on the ac-
tivity of Rad9, consistent with Rad9 dependent repair path-
ways being required to resolve tof1 linked DNA lesions. Al-
though we show that Tof1 has roles in recovering from RS
beyond mediation of the DRC, we cannot rule out a role
for Tof1 downstream of DRC activation. The phosphoryla-
tion state of Tof1 is partially dependent on Mec1/Tel1 ac-
tivity (47) and it is known that Tof1 phosphorylation can
influence fork pausing (48). Therefore, checkpoint depen-
dent phosphorylation of the C terminal half of Tof1 could
be important for recovery of the fork after RS.
In summary, our data argues that the N-terminal half of
Tof1 is linked to DRC functions, potentially through asso-
ciation with Mrc1, that the far C terminus regulates Top1
association with the replisome and that the region of Tof1
between aa 627 and aa 830 is required for stable binding to
Csm3 (Supplementary Figure S5). These data indicate that
Tof1 has roles both in co-ordinating general replisome ar-
chitecture through separate Mrc1 and Csm3 interactions, as
well as specifically recruiting other activities such as Top1 to
the replisome.
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